48 / 88
48
Scientific Programme /
Tuesday, 20 June 2017
WFSBP 2017
TUE
003
Neonatal epigenetic profiling in Danish twins
discordant for psychiatric disorder
Shantel Weinsheimer, Denmark
C. Hansen, A. Starnawska, T. Sparsø, W. Mazin,
M. Bertalan, J. Grauholm, M. Bækvad-Hansen, A. Buil,
D. Hougaard, T. M. Werge
004
Epigenetics in schizophrenia and association with
antipsychotic response to clozapine
Marta Bosia, Italy
T33: PHARMACOLOGY
S-66
SYMPOSIUM
17:00–18:30
Auditorium 15
NMDA receptor antagonists in psychiatry
Chair:
Peter Gass, Germany
Co-Chair: Gerard Sanacora, USA
001
Glutamatergic mechanisms in schizophrenia:
Focus on genetics
Dan Rujescu, Germany
002
Insight into Ketamine's effect via cross-species
translational neuroimaging
Oliver Grimm, Germany
003
Molecular and cellular determinants of the
pleiotropic effects of NMDA receptor antagonists
Dragos Inta, Germany
004
Antidepressant effects of NMDA receptor target-
ing drugs
Gerard Sanacora, USA
FC-06
FREE COMMUNICATION SESSION
17:00–18:30
Auditorium 10
Antipsychotics 1
Chair:
Jimmi Nielsen, Denmark
Co-Chair: Hsien-Yuan Lane, Taiwan
001
Would I take antipsychotics, if I had psychotic
symptoms? Examining social determinants of the
decision to take antipsychotics
Fabrice Berna, France
A. S. Göritz, P.-M. Llorca, P. Vidailhet, G. Fond, S. Moritz
002
Relative NMS risk in older men
Ronald Gurrera, USA
003
Sodium benzoate, a D-amino Acid Oxidase Inhibi-
tor, added to Clozapine for the treatment of schizophre-
nia: A randomized, double-blind, placebo-controlled
trial
Hsien-Yuan Lane, Taiwan
C.-H. Lin
004
Lessons learned from a risperidone therapeutic
drug monitoring database
Georgios Schoretsanitis, Switzerland
005
Revisiting the Increased prevalence of Clozapine
induced cardiotoxicity in Australasia and proposal for a
universal monitoring guideline
Guna Kanniah, New Zealand
S. Kumar
FC-07
FREE COMMUNICATION SESSION
17:00–18:30
Auditorium 11
Anxiety & PTSD
Chair:
Jaanus Harro, Estonia
Co-Chair: Ulrike Schmidt, Germany
001
Inter-hemispheric coordination in posterior sub-
network of default mode network: Putative biomarkers
for depression and anxiety
Chien-Han Lai, Taiwan
Y.-T. Wu
002
Orexin / hypocretin receptor gene (HCRTR1) varia-
tion is associated with aggressive behaviour
Jaanus Harro, Estonia
K. Laas, M. Vaht, J. Parik, J. Mäestu, T. Veidebaum
003
Epigenetic regulation of stress reactivity in Post
Traumatic Stress Disorder (PTSD)
Ulrike Schmidt, Germany
T. F. Windstetter, M. Schreckenbach, B. Novak
004
Clinical and biological characterization of HPA-
axis reactivity endophenotypes in two independent
cohorts of female PTSD patients
Monika Schreckenbach, Germany
T. Kirmeier, U. Schmidt
005
Grief shares circuits with pleasantness: Subliminal
grief priming activates the orbitofrontal cortex to boost
empathic pain
Takuya Yoshiike, Japan
K. Kuriyama, H. Ikeda, H. Ohmura, M. Honma,
Y. Moriguchi, K. Asano, Y. Kim, S. Nakajima
006
Brain-based treatment selection for social anxiety
disorder
Andreas Frick, Sweden
J. Engman, M. Gingnell, I. Alaie, J. Björkstrand,
E.-M. Larsson, K. Wahlstedt, M. Fredrikson, T. Furmark